LAVA Therapeutics NV
Develops bispecific gamma delta T cell engagers for solid and hematologic cancers.
LVTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- NL0015000AG6
- LEI:
- Country:
- United States of America
- Address:
- YALELAAN 62, 0 UTRECHT
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
LAVA Therapeutics NV is a clinical-stage immuno-oncology company developing treatments for cancer. The company's proprietary Gammabody® platform generates novel bispecific gamma delta T cell engager (bsTCE) therapeutics. This approach is designed to activate and direct a unique and abundant subset of immune effector cells, called Vγ9Vδ2 T cells, to tumors. The mechanism aims to selectively kill cancer cells and trigger a durable, cascading immune response. LAVA's portfolio of drug candidates targets both solid tumors and hematologic malignancies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all LAVA Therapeutics NV filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LAVA Therapeutics NV
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LAVA Therapeutics NV via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
